U.S. Food and Drug Administration (FDA) · United States

FDA Antiperspirant Monograph Compliance

Limits antiperspirant claims to monograph-permitted wetness claims, bars sweat claims for deodorants without an active, and requires the kidney-disease warning on labels.

21 U.S.C. 355h(a)(1); OTC Monograph M019 (former 21 CFR 350.50)

What is FDA Antiperspirant Monograph Compliance?

Limits antiperspirant claims to monograph-permitted wetness claims, bars sweat claims for deodorants without an active, and requires the kidney-disease warning on labels. Apply to U.S. labels, listings and ads for antiperspirants and deodorants that make sweat or wetness claims. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

customers, general_audience, general_adults_18plus · OTC Drug, Cosmetics · cpg

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

What does this rule require?

Limits antiperspirant claims to monograph-permitted wetness claims, bars sweat claims for deodorants without an active, and requires the kidney-disease warning on labels.

How can marketing teams comply?

Apply to U.S. labels, listings and ads for antiperspirants and deodorants that make sweat or wetness claims.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (FDA)
Jurisdiction
United States
Official citation
21 U.S.C. 355h(a)(1); OTC Monograph M019 (former 21 CFR 350.50)
Published
2026-11-16
Effective date
2026-05-10
Channel
all_channels
Products
OTC Drug, Cosmetics
Audiences
customers, general_audience, general_adults_18plus

Frequently asked questions

What is FDA Antiperspirant Monograph Compliance?

Limits antiperspirant claims to monograph-permitted wetness claims, bars sweat claims for deodorants without an active, and requires the kidney-disease warning on labels.

Who does this rule apply to?

customers, general_audience, general_adults_18plus · OTC Drug, Cosmetics · cpg

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan